HIGHLIGHTS
- who: Manon Penco-Campillo and colleagues from the Institute for Research on Cancer and Aging (IRCAN), Universitu00e9 Cu00f4te d`Azur, CNRS UMR , and, de Valombrose, Nice, France have published the Article: Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas, in the Journal: Cells 2022, 11, x FOR PEER REVIEW of 12/Oct/2022
- what: The authors demonstrated that C29 has a significant inhibitory effect in several subtypes of MB in_vitro and in_vivo.
- how: The results showed that several members of the ELR+CXCL . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.